Lipocine Net Working Capital from 2010 to 2024
LPCN Stock | USD 5.07 0.20 3.80% |
Net Working Capital | First Reported 2010-12-31 | Previous Quarter 20.2 M | Current Value 25.5 M | Quarterly Volatility 6.8 M |
Check Lipocine financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Lipocine main balance sheet or income statement drivers, such as Interest Expense of 0.0, Selling General Administrative of 5.8 M or Total Revenue of 104.5 K, as well as many exotic indicators such as Price To Sales Ratio of 140, Dividend Yield of 0.0048 or PTB Ratio of 0.96. Lipocine financial statements analysis is a perfect complement when working with Lipocine Valuation or Volatility modules.
Lipocine | Net Working Capital |
Latest Lipocine's Net Working Capital Growth Pattern
Below is the plot of the Net Working Capital of Lipocine over the last few years. It is Lipocine's Net Working Capital historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Lipocine's overall financial position and show how it may be relating to other accounts over time.
Net Working Capital | 10 Years Trend |
|
Net Working Capital |
Timeline |
Lipocine Net Working Capital Regression Statistics
Arithmetic Mean | 21,309,145 | |
Geometric Mean | 20,550,429 | |
Coefficient Of Variation | 31.83 | |
Mean Deviation | 4,634,397 | |
Median | 18,874,165 | |
Standard Deviation | 6,783,496 | |
Sample Variance | 46T | |
Range | 26.1M | |
R-Value | 0.47 | |
Mean Square Error | 38.7T | |
R-Squared | 0.22 | |
Significance | 0.08 | |
Slope | 708,505 | |
Total Sum of Squares | 644.2T |
Lipocine Net Working Capital History
About Lipocine Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Lipocine income statement, its balance sheet, and the statement of cash flows. Lipocine investors use historical funamental indicators, such as Lipocine's Net Working Capital, to determine how well the company is positioned to perform in the future. Although Lipocine investors may use each financial statement separately, they are all related. The changes in Lipocine's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Lipocine's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Lipocine Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Lipocine. Please read more on our technical analysis and fundamental analysis pages.
Last Reported | Projected for Next Year | ||
Net Working Capital | 20.2 M | 25.5 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of Lipocine Correlation against competitors. To learn how to invest in Lipocine Stock, please use our How to Invest in Lipocine guide.Note that the Lipocine information on this page should be used as a complementary analysis to other Lipocine's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Complementary Tools for Lipocine Stock analysis
When running Lipocine's price analysis, check to measure Lipocine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lipocine is operating at the current time. Most of Lipocine's value examination focuses on studying past and present price action to predict the probability of Lipocine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lipocine's price. Additionally, you may evaluate how the addition of Lipocine to your portfolios can decrease your overall portfolio volatility.
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
CEOs Directory Screen CEOs from public companies around the world | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data |
Is Lipocine's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lipocine. If investors know Lipocine will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lipocine listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.14) | Revenue Per Share (0.54) | Quarterly Revenue Growth (1.00) | Return On Assets (0.37) | Return On Equity (0.58) |
The market value of Lipocine is measured differently than its book value, which is the value of Lipocine that is recorded on the company's balance sheet. Investors also form their own opinion of Lipocine's value that differs from its market value or its book value, called intrinsic value, which is Lipocine's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lipocine's market value can be influenced by many factors that don't directly affect Lipocine's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lipocine's value and its price as these two are different measures arrived at by different means. Investors typically determine if Lipocine is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lipocine's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.